A previous study revealed that the reactivation of wild-type NPRL2, via recombinant adenoviral vector-mediated transfer, in lung cancer cells with abnormal 3p21.3 genes, inhibited tumor cell growth by inducing apoptosis and altering cell kinetics in vitro. Here, NPRL2 is linked to lung carcinoma.